CTDP-002

N/A

Report date: 2025/01/26 17:15:01
NME

Base Information

Drug NameCTDP-002
Drug Alias Nameorexin 1 antagonists (Chronos)CTDP-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOrexin receptor type 1 antagonists
TargetsOrexin receptor type 1
Therapy Area/IndicationsBinge-Eating DisorderTobacco Use DisorderAlcoholism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesShire
China Registration ClassN/A

Develop Information

Active CompaniesTheraCryf PLC
Inactive CompaniesChronos Therapeutics Ltd
Active IndicationsBinge-Eating DisorderTobacco Use DisorderAlcoholism
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A